文献速递泌尿生殖腹部MR

基于多参数磁共振成像的列线图模型鉴别前列腺导管内癌与前列腺腺泡腺癌

Nomogram Models for Distinguishing Intraductal Carcinoma of the Prostate From Prostatic Acinar Adenocarcinoma Based on Multiparametric Magnetic Resonance Imaging.
PubMed 文献 · Korean J Radiol · 2023-01-01

本研究纳入106例高比例导管内癌、105例低比例导管内癌和168例前列腺腺泡腺癌患者,比较其治疗前多参数MRI特征并构建列线图模型。导管内癌较腺泡腺癌肿瘤更大、更具侵袭和转移特征,且弥散受限更明显;高比例导管内癌较低比例导管内癌更常见包膜外侵犯和盆腔淋巴结肿大,且ADC比值更低。仅基于影像特征的列线图鉴别导管内癌与腺泡腺癌的ROC-AUC为0.797,鉴别高比例导管内癌与低比例导管内癌及腺泡腺癌的ROC-AUC为0.777。

要点

  • 导管内癌较腺泡腺癌肿瘤直径更大,侵袭和转移征象更常见(P < 0.001)。
  • 高比例导管内癌较低比例导管内癌包膜外侵犯和盆腔淋巴结肿大分布更广,ADC比值更低(P < 0.05)。
  • 仅基于影像特征的列线图鉴别导管内癌与腺泡腺癌ROC-AUC为0.797,鉴别高比例导管内癌与低比例导管内癌及腺泡腺癌ROC-AUC为0.777。

核心结论

  • 导管内癌更可能表现为肿瘤更大、更具侵袭性和转移性,且弥散受限明显;包膜外侵犯、盆腔淋巴结肿大和较低ADC比值更可能见于高比例导管内癌,也是两个列线图中预测导管内癌和高比例导管内癌最有用的变量。

研究设计与样本

  • 回顾性纳入2015年1月至2020年12月间接受治疗前多参数MRI的106例高比例导管内癌、105例低比例导管内癌和168例前列腺腺泡腺癌患者,比较影像参数并用多变量逻辑回归构建列线图,在建模样本内用ROC-AUC评估区分性能,无独立验证样本。

关键影像表现/征象

  • 导管内癌组较腺泡腺癌组肿瘤直径更大,侵袭和转移特征更常见(P < 0.001)。
  • 高比例导管内癌组较低比例导管内癌组包膜外侵犯和盆腔淋巴结肿大分布更广,ADC比值更低(P < 0.05)。

诊断标准与关键数值

  • 仅基于影像特征的逐步模型鉴别导管内癌与腺泡腺癌的ROC-AUC为0.797(95%CI 0.750-0.843)。
  • 仅基于影像特征的逐步模型鉴别高比例导管内癌与低比例导管内癌及腺泡腺癌的ROC-AUC为0.777(95%CI 0.727-0.827)。

临床应用与阅片要点

  • 阅片时注意评估肿瘤直径、侵袭和转移征象(如包膜外侵犯、盆腔淋巴结肿大)以及ADC比值,这些特征有助于鉴别导管内癌与腺泡腺癌并提示高比例导管内癌。

局限性

  • 模型在推导样本内评估区分性能,无独立验证样本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare multiparametric magnetic resonance imaging (MRI) features of intraductal carcinoma of the prostate (IDC-P) with those of prostatic acinar adenocarcinoma (PAC) and develop prediction models to distinguish IDC-P from PAC and IDC-P with a high proportion (IDC ≥ 10%, hpIDC-P) from IDC-P with a low proportion (IDC < 10%, lpIDC-P) and PAC.

MATERIALS AND METHODS: One hundred and six patients with hpIDC-P, 105 with lpIDC-P and 168 with PAC, who underwent pretreatment multiparametric MRI between January 2015 and December 2020 were included in this study. Imaging parameters, including invasiveness and metastasis, were evaluated and compared between the PAC and IDC-P groups as well as between the hpIDC-P and lpIDC-P subgroups. Nomograms for distinguishing IDC-P from PAC, and hpIDC-P from lpIDC-P and PAC, were made using multivariable logistic regression analysis. The discrimination performance of the models was assessed using the receiver operating characteristic area under the curve (ROC-AUC) in the sample, where the models were derived from without an independent validation sample.

RESULTS: The tumor diameter was larger and invasive and metastatic features were more common in the IDC-P than in the PAC group (P < 0.001). The distribution of extraprostatic extension (EPE) and pelvic lymphadenopathy was even greater, and the apparent diffusion coefficient (ADC) ratio was lower in the hpIDC-P than in the lpIDC-P group (P < 0.05). The ROC-AUCs of the stepwise models based solely on imaging features for distinguishing IDC-P from PAC and hpIDC-P from lpIDC-P and PAC were 0.797 (95% confidence interval, 0.750-0.843) and 0.777 (0.727-0.827), respectively.

CONCLUSION: IDC-P was more likely to be larger, more invasive, and more metastatic, with obviously restricted diffusion. EPE, pelvic lymphadenopathy, and a lower ADC ratio were more likely to occur in hpIDC-P, and were also the most useful variables in both nomograms for predicting IDC-P and hpIDC-P.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Yang L, Li XM, Zhang MN, et al. Nomogram Models for Distinguishing Intraductal Carcinoma of the Prostate From Prostatic Acinar Adenocarcinoma Based on Multiparametric Magnetic Resonance Imaging. Korean J Radiol. 2023. PMID: 37404109. doi:10.3348/kjr.2022.1022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。